Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanjia Chen

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Vaccines|May 25, 2024
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB ReinfectionXun Wang, Meng Zhang, Kaifeng Wei, et al.
Communications Biology|March 6, 2025
Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infectionLei Yu, Yajie Wang, Yuanchen Liu, et al.
Cell Host & Microbe|November 29, 2023
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine boosterXun Wang, Shujun Jiang, Wentai Ma, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 9, 2024
Efficacy and Safety of Chinese Herbal Medicine in Patients with Acute Intracerebral Hemorrhage: Protocol for a Randomized Placebo-Controlled Double-Blinded Multicenter TrialYang Zhao, Wanzhen Cui, Tingting Xie, et al.
Cell Discovery|February 6, 2024
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccinationXiaoyu Zhao, Tianyi Qiu, Xiner Huang, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Vaccines|May 25, 2024
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB ReinfectionXun Wang, Meng Zhang, Kaifeng Wei, et al.
Communications Biology|March 6, 2025
Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infectionLei Yu, Yajie Wang, Yuanchen Liu, et al.
Cell Host & Microbe|November 29, 2023
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine boosterXun Wang, Shujun Jiang, Wentai Ma, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 9, 2024
Efficacy and Safety of Chinese Herbal Medicine in Patients with Acute Intracerebral Hemorrhage: Protocol for a Randomized Placebo-Controlled Double-Blinded Multicenter TrialYang Zhao, Wanzhen Cui, Tingting Xie, et al.
Cell Discovery|February 6, 2024
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccinationXiaoyu Zhao, Tianyi Qiu, Xiner Huang, et al.
Pageof 7